Last updated on February 2019

Graduate II Study: Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)


Brief description of study

Are you starting to experience memory problems?

Are slight memory problems affecting your ability to do regular activities?

Has anyone noticed a change in your memory?

Do you have a family history of Alzheimer’s Disease?

If so, you may be experiencing the first signs of memory loss. You may qualify for an investigational medication research study for people with early memory loss.

 

Clinical Study Identifier: TX216930

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.